HDFC Life slips 4% after Q4FY26 miss; FY27 recovery in focus

What happened to HDFC Life stock

HDFC Life Insurance shares fell sharply on Friday, April 17, 2026, after the insurer reported a weaker-than-expected March quarter. In intraday trade on the BSE, the stock slipped 4% to ₹606.2 per share, while the Sensex was flat. On the NSE, the stock also emerged among the biggest losers, slipping over 3% to ₹610.40 at one point, even as the Nifty 50 rose 0.33% to 24,276.

The negative reaction was driven less by headline profit and more by operating metrics and margins. Brokerages and analysts flagged a miss on Annualised Premium Equivalent (APE), pressure on Value of New Business (VNB) and VNB margin, and softer persistency trends in some buckets. Several houses also pointed to regulatory and tax-related headwinds that affected FY26.

Why the market reacted despite profit growth

For Q4FY26, HDFC Life reported net profit of ₹495.6 crore, up 4% year-on-year, but the quarter was affected by changes related to GST and labour code regulations. Net premium income rose 8.68% year-on-year to ₹25,829.43 crore.

However, APE for the quarter came in at ₹5,254 crore, up about 1% year-on-year, but below the consensus estimate of ₹5,329 crore cited in the article. VNB was ₹1,261 crore versus an estimate of ₹1,269 crore, and declined 8.36% year-on-year. The VNB margin contracted to 24% from 26.5% in Q4FY25.

In a life insurer, the market often pays closer attention to VNB and margins than to quarterly profit alone. That is because VNB reflects the profitability of new policies written during the period, and margin compression can change the earnings trajectory even when reported profit grows.

Competitive pricing and channel pressures

Analysts cited aggressive non-par product pricing by competitors as a key driver behind the miss, especially in the HDFC Bank channel. According to the article, competitive pricing led to a loss of counter share in that channel, which weighed on APE and profitability metrics.

The article also pointed to lower offtake of non-par products leading to lower margin in the savings business. At the same time, the impact of GST input tax credit (ITC) loss and a new surrender regulation during the year were flagged as factors that affected margins.

FY26 numbers show growth, but margins eased

For the full financial year FY26, HDFC Life’s APE increased 8% year-on-year to about ₹16,640 crore. For the same period, VNB was up 2% year-on-year to ₹4,030 crore (also reported as ₹4,034 crore in another section of the article), with a VNB margin of 24.2% versus 25.6% in FY25.

The company reported profit after tax of ₹1,910 crore for FY26, up 6% year-on-year. The article also noted underlying profit growth of 16% after adjusting for one-off impacts.

Persistency was mixed. HDFC Life said its persistency ratios declined year-on-year across 13-month, 25-month, and 49-month tenures in Q4FY26, while 37-month and 61-month persistency improved.

Asset base and scale: AUM continues to rise

HDFC Life reported total assets under management (AUM) of ₹380,000 crore as of March 2026, up 12% year-on-year (₹3.8 trillion as stated in the article). The AUM growth matters because a larger base can support investment income and balance-sheet stability, although the market’s immediate focus remained on new business profitability and competitive conditions.

What brokerages said: buy ratings, but cuts to forecasts

Brokerages cited in the article highlighted pressure points across growth and profitability metrics. HSBC said the quarter was soft across parameters, including APE, margins, persistency and embedded value (EV) growth. It maintained a buy rating with a target price of ₹690.

JPMorgan noted subdued operating performance, highlighting weak APE growth (0.4% year-on-year as cited) and a decline in VNB margin to 23.9%. It said competitive intensity weighed on retail growth and that pressure in the non-par segment is increasing. JPMorgan retained an overweight rating with a target price of ₹810, while also expecting near-term growth to remain weak.

The article also stated that analysts cut earnings estimates for FY27 and FY28, factoring in the weaker FY26 outcome, but remained cautiously optimistic about growth and margin recovery from FY27 onward.

Stock performance and valuation debate

The article carried multiple data points on performance and valuation, reflecting different snapshots and sources. One section said HDFC Life shares were down 15.2% over the past year while the benchmark gained 1.8%. Another section compared HDFC Life’s one-year decline (about 11%) with SBI Life’s gain (about 17%). Elsewhere, it cited a one-year return of 9.26% for HDFC Life versus 6.90% for the Sensex.

On valuation, the article cited trailing P/E ranges of about 68.97 to 73.06 in one section and 78.32 in another, while also noting an insurance sector average P/E around 21.71 to 21.22. It also mentioned SBI Life trading at a P/E of about 81.87. Separately, market capitalisation was described in a range of about ₹134,000 crore to ₹140,000 crore in one section, and as ₹148,034 crore in another.

These figures underline the core market debate: HDFC Life’s premium valuation leaves less room for disappointment when growth or margins undershoot expectations.

Key numbers at a glance

Market impact: what changed after the print

The immediate market impact was a sharp underperformance versus broader indices on the day of results, with the stock down around 4% intraday. The reaction reflected concern over competitive pricing in the non-par segment and channel-level share loss, as described in the article.

Cuts to FY27 and FY28 earnings estimates can also affect near-term sentiment, especially for a stock that multiple sections of the article describe as trading at a valuation premium to the sector average. At the same time, buy and overweight ratings and target prices of ₹690 and ₹810 suggest some brokerages believe the weakness is cyclical or execution-linked rather than structural.

Analysis: why FY27 recovery has become the key signal

The article’s central theme is that FY26 was affected by a combination of competitive intensity, product mix, and regulatory and tax-related disruptions. With VNB margins down to 24% in Q4FY26 and 24.2% for FY26, the next leg for the stock is likely to depend on whether margins stabilise and whether APE growth improves meaningfully.

Execution in the HDFC Bank channel, product pricing discipline in non-par, and persistency trends across key tenure buckets are likely to be closely tracked because they directly influence VNB and embedded value compounding. Broker commentary in the article frames these as the main triggers, while still acknowledging near-term softness.

Conclusion

HDFC Life’s 4% fall followed a Q4FY26 print where APE and VNB metrics came in below estimates and margins contracted year-on-year. While analysts have cut FY27 and FY28 earnings estimates, some brokerages retained positive ratings and targets, hinging their stance on improved execution and a recovery in growth and margins from FY27.